BlackRock, Inc. 13D and 13G filings for Cara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-08 4:32 pm Sale |
2024-06-30 | 13G | Cara Therapeutics, Inc. CARA |
BlackRock Inc. BLK |
62,059 1.400% |
-234,129 (-79.05%) |
Filing |
| 2024-01-29 3:26 pm Sale |
2023-12-31 | 13G | Cara Therapeutics, Inc. CARA |
BlackRock Inc. BLK |
296,188 6.500% |
-12,309 (-3.99%) |
Filing |
| 2023-07-07 4:35 pm Sale |
2023-06-30 | 13G | Cara Therapeutics, Inc. CARA |
BlackRock Inc. BLK |
308,497 6.900% |
-335,713 (-52.11%) |
Filing |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | Cara Therapeutics, Inc. CARA |
BlackRock Inc. BLK |
644,211 14.400% |
0 (Unchanged) |
Filing |
| 2023-01-20 09:43 am Purchase |
2022-12-31 | 13G | Cara Therapeutics, Inc. CARA |
BlackRock Inc. BLK |
644,211 14.400% |
44,284 (+7.38%) |
Filing |
| 2022-01-28 1:54 pm Sale |
2021-12-31 | 13G | Cara Therapeutics, Inc. CARA |
BlackRock Inc. BLK |
599,927 13.500% |
-2,929 (-0.49%) |
Filing |
| 2021-05-07 5:09 pm Purchase |
2021-04-30 | 13G | Cara Therapeutics, Inc. CARA |
BlackRock Inc. BLK |
602,856 14.500% |
300,168 (+99.17%) |
Filing |
| 2021-01-28 5:56 pm Purchase |
2020-12-31 | 13G | Cara Therapeutics, Inc. CARA |
BlackRock Inc. BLK |
302,689 7.300% |
7,163 (+2.42%) |
Filing |